ENDEAVOUR unites 21 promising lung cancer specialists with internationally recognized experts to foster collaboration and improve patient outcomes Three-year program aims to promote excellence in research and enhance clinical knowledge At launch event in Madrid participants initiated four collaborative research projects which will be developed under expert guidance MADRID–(BUSINESS WIRE)–The ENDEAVOUR lung cancer program, a … [Read more…]

ATLANTA–(BUSINESS WIRE)–Guardian Pharmacy Services, Inc. (“Guardian”) (NYSE: GRDN) today announced the pricing of the previously announced underwritten public offering (the “Offering”) of 7,500,000 shares of its Class A common stock, at a public offering price of $21.00 per share, of which 6,059,553 shares will be sold by certain selling stockholders and 1,440,447 shares will be … [Read more…]

Flatiron’s 2025 ASCO research showcases the power of longitudinal, real-world oncology data and innovative AI-driven methodologies to generate actionable evidence, address health equity, and accelerate progress in cancer care and clinical research. NEW YORK–(BUSINESS WIRE)–Please remove the partners listed under “Real-world (rw) ctDNA testing trends and associated outcomes in patients (pts) with early stage breast … [Read more…]

TORONTO–(BUSINESS WIRE)–dentalcorp Holdings Ltd. (“Dentalcorp” or the “Company“), (TSX: DNTL) Canada’s largest and one of North America’s fastest growing networks of dental practices, announced today the results of its Annual General and Special Meeting of Shareholders (“AGM“) held on Thursday, May 22, 2025. At the AGM, Dentalcorp shareholders voted on the following matters, the full … [Read more…]

Ilana Golant Statement on New White House Report NEW YORK–(BUSINESS WIRE)–#foodallergy–The Food Allergy Fund applauds the release of the Make America Healthy Again report, which provides a roadmap for addressing the childhood chronic disease crisis, and thanks the MAHA Commission for prioritizing bold, science-driven solutions to address the health challenges, such as food allergies, that … [Read more…]

At the EuroPCR 2025 Congress – Paris Results confirm the promise of non-invasive ultrasound therapy (NIUT) previously observed in earlier clinical studies. 91% of patients were free of major adverse cardiac events (MACE) at 30 days (achieving the primary endpoint objective MACE ≤ 25%). 85% of patients experienced an improvement or stabilization in their NYHA … [Read more…]

Session showcases how to tell your value story and gain support for your company’s product offering BOSTON–(BUSINESS WIRE)–LaVoieHealthScience today announced it will lead an educational session at the 2025 BIO International Convention, taking place June 16–19 at the Boston Convention & Exhibition Center. Donna LaVoie, President & CEO of LaVoieHealthScience, who led this workshop at … [Read more…]

RAHWAY, N.J.–(BUSINESS WIRE)–Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that Robert M. Davis, chairman and chief executive officer, and Dr. Dean Y. Li, executive vice president and president, Merck Research Laboratories, are scheduled to participate in a fireside chat at the Bernstein 41st Annual Strategic Decisions Conference … [Read more…]

PARIS–(BUSINESS WIRE)–Edwards Lifesciences (NYSE: EW) today announced new economic and clinical evidence on severe aortic stenosis (AS) presented as a late-breaking clinical trial at EuroPCR 2025, further contributing to the extensive body of research on this disease. The results of a new real-world study of more than 24,000 patients demonstrated that intervening on the disease … [Read more…]

HARRISBURG, Pa.–(BUSINESS WIRE)–#maternalhealth–The Pennsylvania Perinatal Quality Collaborative (PA PQC) is pleased to announce the recipients of its second annual Perinatal Quality Improvement Designation Awards which were presented at its annual conference in Altoona on May 21, 2025. Designation awards and levels are based on meeting quality improvement milestone criteria over a 12-month period, starting from … [Read more…]